RMC No. 125-2022: Publishes the August 17, 2022 letter from the Food and Drug Administration of the DOH endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act)

Key points

1. Update to the list. The letter comes from FDA Director General Samuel A. Zacate. The list deletes certain medicines prescribed for COVID-19 treatment.
2. When the exemption takes effect. As clarified under Q&A No. 1 of RMC No. 99-2021, the VAT exemption of the covered medicines and medical devices takes effect on the date the FDA publishes the updates to the list.

Deadlines and effectivity

• FDA letter dated August 17, 2022
• VAT exemption effective on the date of FDA publication of the updates